Navigation Links
Interleukin Genetics Retains Top Life Science Communications Firms
Date:3/18/2008

Stern Investor Relations and LaVoie Group Selected as IR, PR Agencies of

Record

WALTHAM, Mass., March 18 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc., (Amex: ILI), announced today that it has retained two premier life science communications firms, Stern Investor Relations, Inc., and LaVoie Group, as agencies of record to provide investor relations and public relations services, respectively.

The two firms will provide strategic counsel and execution, will lead efforts to communicate Interleukin Genetics' vision to use the science of applied genetics to personalize health management and will support the Company's strategy to establish additional partnerships and relationships with biotechnology and pharmaceutical companies.

Lewis H. Bender, Chief Executive Officer commented, "Interleukin Genetics has a strong message on the value of diagnostic testing to empower consumers to personalize their health. With the addition of these two firms, I am confident that we will deliver our message more effectively to our key constituencies."

About LaVoie Group

LaVoie Group provides strategic, integrated marketing and communications- including marketing strategy, corporate communications, as well as public and investor relations to life sciences and healthcare companies. LaVoie Group's clients range from start-ups to industry leaders. For more information, visit http://www.lavoiegroup.com.

About Stern Investor Relations

Stern Investor Relations provides investor relations consulting services to biotechnology and healthcare companies. Stern IR develops and implements strategic investor relations programs design
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
2. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
5. Interleukin Genetics Announces Management and Board Appointments
6. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. deCODE Genetics Announces Full-year 2007 Financial Results
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
10. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
11. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 ,, 3Q09 Corpor...enza(TM) E.U. Marketing Authorization to Astellas ...commercial readiness activities Expanded manageme...eting; and Director, Commercial Operations Appoin...udit Committee chairman , Upcoming 2009 Mil...
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)...ewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bullet...cer, President and CEO of Imagenetix, will be pres...CRO Conference on Thursday, December 3rd, at 10:30...bout LD MICRO ,, LD MICRO is a by-invitation on...lued companies in the micro-cap space. Since 2002,...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...s available for technology companies as part of a ... Standards and Technologys Advanced Technology Pr...ligible for an award, and proposals in all technol...s program are a primary source of R&D capital for ...ve an impact across several industrial and social ...
...ed today it has been chosen again to provide scori...nsin-Madisons Camp Randall Stadium and Kohl Center...uipment provided by the South Dakota-based company...eds $5 million with installation scheduled to be c...ll and 2005 Badger basketball seasons. , ,These in...
...ced today they have signed a distribution agreemen...t distributor of advanced clinical in-vitro diagno...ys distribution agreement announced last Wednesday...oal; to create innovative solutions that provide s...hly skilled team provides specialized diagnostic p...
Other Biology Technology:Daktronics to provide Camp Randall and Kohl Center with scoreboards, display systems 2
(Date:11/8/2009)...TTE, Ind. - Researchers at Purdue University have ...rve fibers in spinal cord injuries using nano-sphe...after an accident. , The synthetic "copolymer mi...ers in diameter, or roughly 100 times smaller than... have been studying how to deliver drugs for cance...
(Date:11/6/2009)...gistration is now open for the Society of Interven...cology (IO) Therapies" Webinar, which will provide...ter treatment of liver tumors, kidney tumor ablati...nization of physicians, scientists and allied heal...lth through pioneering advances in image-guided th...
(Date:11/6/2009)...ov. 6 Auburn Hills, MI-based Law E... installing its locker system and patent-pending B....S. Department of Health and Human Services, Natio...MD. The locker system will support the NIH,s enti... our nation,s medical research agency. The projec...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 1CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 1Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 3Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 1Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 2Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 3
...n the cell can serve as an advanced tool for mappi...technique in which non-invasive magnetic resonance... results of this research, conducted by Prof. Mich...egulation Department, were published in the resear...Batya Cohen of the Institute,s Molecular Genetics ...
...Hopkins show that stem cell therapy can be used ef...farction, in pigs. In just two months, stem cells ...ted into the animal,s damaged heart restored heart...percent to 75 percent. , The Hopkins findings, fir...ions of the American Heart Association, are to be ...
... relative excavated last year at Petrified Forest ...ries of how and where the dinosaurs arose more tha... Period. , The animal, one of many creatures from...s thought to be an ancestor of the plant-eating or...tops, which roamed the world millions of years lat...
Other Biology News:Novel live reporting system to track cells 2Stem cell therapy successfully treats heart attack in animals 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 3Agilent Technologies introduces high-capacity human protein removal system for proteomics research 4
...gands\n\nReceptor-related research has long been e...abeled ligands selected to keep pace with new disc...ts and services for receptor research and drug dis...igands. If you do not find exactly what you need, ...
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Rabbit Anti-Mouse Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...methylation is an irreversible post translational ...o protein activity. At least three types of PRMT e...ese enzymes have been shown to have essential regu... several fundamental areas. These protein include ...
Biology Products: